Compass Therapeutics Appoints Thomas Schuetz As President And CEO, Effective May 28, 2024; Vered Bisker-Leib Has Stepped Down
Portfolio Pulse from Benzinga Newsdesk
Compass Therapeutics has appointed Thomas Schuetz as President and CEO, effective May 28, 2024. Vered Bisker-Leib has stepped down but will remain as a Senior Consultant for the next 15 months.
May 28, 2024 | 8:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Compass Therapeutics has announced a leadership change with Thomas Schuetz appointed as President and CEO, effective May 28, 2024. Vered Bisker-Leib has stepped down but will remain as a Senior Consultant for 15 months.
The appointment of a new CEO can bring fresh perspectives and strategies, potentially boosting investor confidence. The transition period with Bisker-Leib remaining as a consultant ensures continuity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100